Aryeh Jason
SEC CIK 1376960 · EDGAR
BoughtSold
Most active insiders at LGND, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Espinoza Octavio | CFO | — | $13.03M |
| 2 | Reardon Andrew | CLO, Sec | — | $8.77M |
| 3 | Haas Jason | Dir | — | $3.74M |
| 4 | LAMATTINA JOHN L | Dir | — | $2.44M |
| 5 | Gray Nancy Ryan | Dir | — | $1.35M |
| 6 | Aryeh Jason | Dir | — | $1.25M |
| 7 | KOZARICH JOHN W | Dir | — | $1.20M |
| 8 | Sabba Stephen L | Dir | — | $1.16M |
| 9 | Zimmermann Martine | Dir | — | $342.0K |
| 10 | Davis Todd C | CEO, Dir | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-12 17:27 | 2026-06-05 | LGND | LIGAND PHARMACEUTICALS INC | Aryeh Jason | Dir | A - Grant | $0.00 | +836 | 107.6K | +0.8% | $0 |
| DM | 2026-06-12 17:27 | 2026-06-10+ | LGND | LIGAND PHARMACEUTICALS INC | Aryeh Jason | Dir | S - Sale | $250.00 | -5,000 | 102.6K | -5% | -$1.25M |
| 2026-06-05 16:46 | 2026-06-04 | LFCR | LIFECORE BIOMEDICAL, INC. DE | Aryeh Jason | Dir | A - Grant | — | +25.9K | 70.0K | +59% | — | |
| 2026-05-20 08:00 | 2026-05-18 | OBIO | Orchestra BioMed Holdings, Inc. | Aryeh Jason | Dir | P - Purchase | $3.75 | +665 | 118.1K | +0.6% | +$2,494 | |
| 2026-05-19 08:00 | 2026-05-15 | OBIO | Orchestra BioMed Holdings, Inc. | Aryeh Jason | Dir | P - Purchase | $3.90 | +8,971 | 117.5K | +8% | +$35.0K | |
| D | 2025-12-08 | 2025-12-08 | LGND | LIGAND PHARMACEUTICALS INC | Aryeh Jason | Dir | M - OptEx | $69.51 | +2,034 | 71.3K | +3% | +$141.4K |
| M | 2025-09-24 | 2025-09-23 | LGND | LIGAND PHARMACEUTICALS INC | Aryeh Jason | Dir | S - Sale | $170.81 | -10.0K | 70.2K | -12% | -$1.71M |
| 2025-09-19 | 2025-09-19 | OBIO | Orchestra BioMed Holdings, Inc. | Aryeh Jason | Dir | P - Purchase | $2.45 | +1,000 | 108.5K | +0.9% | +$2,450 | |
| 2025-08-08 | 2025-08-07 | OBIO | Orchestra BioMed Holdings, Inc. | Aryeh Jason | Dir | A - Grant | $0.00 | +15.0K | 107.5K | +16% | $0 | |
| 2025-07-17 | 2025-07-15 | LFCR | LIFECORE BIOMEDICAL, INC. DE | Aryeh Jason | Dir | A - Grant | — | +19.5K | 44.1K | +79% | — | |
| D | 2025-06-27 | 2025-06-24 | OBIO | Orchestra BioMed Holdings, Inc. | Aryeh Jason | Dir | A - Grant | $0.00 | +12.4K | 92.5K | +16% | $0 |
| D | 2025-06-10 | 2025-06-06 | LGND | LIGAND PHARMACEUTICALS INC | Aryeh Jason | Dir | A - Grant | $0.00 | +1,209 | 79.3K | +2% | $0 |
| D | 2024-12-30 | 2024-12-27 | OBIO | Orchestra BioMed Holdings, Inc. | Aryeh Jason | Dir | M - OptEx | $4.30 | +11.7K | 80.1K | +17% | +$50.3K |
| 2024-08-21 | 2024-08-19 | LFCR | LIFECORE BIOMEDICAL, INC. DE | Aryeh Jason | Dir | A - Grant | — | +24.6K | 24.6K | New | — | |
| D | 2024-06-21 | 2024-06-20 | OBIO | Orchestra BioMed Holdings, Inc. | Aryeh Jason | Dir | A - Grant | $0.00 | +5,376 | 68.4K | +9% | $0 |
| D | 2024-06-18 | 2024-06-14 | LGND | LIGAND PHARMACEUTICALS INC | Aryeh Jason | Dir | A - Grant | $0.00 | +1,252 | 78.1K | +2% | $0 |
| D | 2024-05-02 | 2024-04-30 | LGND | LIGAND PHARMACEUTICALS INC | Aryeh Jason | Dir | M - OptEx | $52.30 | +2,406 | 76.8K | +3% | +$125.8K |
| D | 2024-03-06 | 2024-03-05 | LGND | LIGAND PHARMACEUTICALS INC | Aryeh Jason | Dir | M - OptEx | $39.35 | +2,893 | 74.4K | +4% | +$113.8K |
| D | 2023-06-13 | 2023-06-09 | LGND | LIGAND PHARMACEUTICALS INC | Aryeh Jason | Dir | A - Grant | $0.00 | +1,142 | 71.5K | +2% | $0 |
| D | 2023-05-05 | 2023-04-12 | OBIO | Orchestra BioMed Holdings, Inc. | Aryeh Jason | Dir | M - OptEx | — | +11.2K | 63.0K | +22% | — |
| D | 2023-01-30 | 2023-01-26 | OBIO | Orchestra BioMed Holdings, Inc. | Aryeh Jason | Dir | A - Grant | — | +51.7K | 51.7K | New | — |
| D | 2022-06-13 | 2022-06-10 | LGND | LIGAND PHARMACEUTICALS INC | Aryeh Jason | Dir | A - Grant | $0.00 | +1,004 | 69.7K | +1% | $0 |
Purchase Sale Sale after option exercise All abbreviations